These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 23495007)
1. The Fgfr2(S252W/+) mutation in mice retards mandible formation and reduces bone mass as in human Apert syndrome. Zhou X; Pu D; Liu R; Li X; Wen X; Zhang L; Chen L; Deng M; Liu L Am J Med Genet A; 2013 May; 161A(5):983-92. PubMed ID: 23495007 [TBL] [Abstract][Full Text] [Related]
2. Excessive osteoclast activation by osteoblast paracrine factor RANKL is a major cause of the abnormal long bone phenotype in Apert syndrome model mice. Shin HR; Kim BS; Kim HJ; Yoon H; Kim WJ; Choi JY; Ryoo HM J Cell Physiol; 2022 Apr; 237(4):2155-2168. PubMed ID: 35048384 [TBL] [Abstract][Full Text] [Related]
3. The study of abnormal bone development in the Apert syndrome Fgfr2+/S252W mouse using a 3D hydrogel culture model. Yang F; Wang Y; Zhang Z; Hsu B; Jabs EW; Elisseeff JH Bone; 2008 Jul; 43(1):55-63. PubMed ID: 18407821 [TBL] [Abstract][Full Text] [Related]
4. Mandibular dysmorphology due to abnormal embryonic osteogenesis in FGFR2-related craniosynostosis mice. Motch Perrine SM; Wu M; Stephens NB; Kriti D; van Bakel H; Jabs EW; Richtsmeier JT Dis Model Mech; 2019 May; 12(5):. PubMed ID: 31064775 [TBL] [Abstract][Full Text] [Related]
5. Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice. Wang Y; Sun M; Uhlhorn VL; Zhou X; Peter I; Martinez-Abadias N; Hill CA; Percival CJ; Richtsmeier JT; Huso DL; Jabs EW BMC Dev Biol; 2010 Feb; 10():22. PubMed ID: 20175913 [TBL] [Abstract][Full Text] [Related]
6. Soluble form of FGFR2 with S252W partially prevents craniosynostosis of the apert mouse model. Morita J; Nakamura M; Kobayashi Y; Deng CX; Funato N; Moriyama K Dev Dyn; 2014 Apr; 243(4):560-7. PubMed ID: 24259495 [TBL] [Abstract][Full Text] [Related]
7. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis. Yin L; Du X; Li C; Xu X; Chen Z; Su N; Zhao L; Qi H; Li F; Xue J; Yang J; Jin M; Deng C; Chen L Bone; 2008 Apr; 42(4):631-43. PubMed ID: 18242159 [TBL] [Abstract][Full Text] [Related]
8. Aberrantly activated Wnt/β-catenin pathway co-receptors LRP5 and LRP6 regulate osteoblast differentiation in the developing coronal sutures of an Apert syndrome (Fgfr2 Min Swe NM; Kobayashi Y; Kamimoto H; Moriyama K Dev Dyn; 2021 Mar; 250(3):465-476. PubMed ID: 32822074 [TBL] [Abstract][Full Text] [Related]
9. Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts. Suzuki H; Suda N; Shiga M; Kobayashi Y; Nakamura M; Iseki S; Moriyama K J Cell Physiol; 2012 Sep; 227(9):3267-77. PubMed ID: 22105374 [TBL] [Abstract][Full Text] [Related]
10. A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome. Tanimoto Y; Yokozeki M; Hiura K; Matsumoto K; Nakanishi H; Matsumoto T; Marie PJ; Moriyama K J Biol Chem; 2004 Oct; 279(44):45926-34. PubMed ID: 15310757 [TBL] [Abstract][Full Text] [Related]
11. A Ser252Trp mutation in fibroblast growth factor receptor 2 (FGFR2) mimicking human Apert syndrome reveals an essential role for FGF signaling in the regulation of endochondral bone formation. Chen P; Zhang L; Weng T; Zhang S; Sun S; Chang M; Li Y; Zhang B; Zhang L PLoS One; 2014; 9(1):e87311. PubMed ID: 24489893 [TBL] [Abstract][Full Text] [Related]
12. Effects of FGFR Signaling on Cell Proliferation and Differentiation of Apert Dental Cells. Lu C; Huguley S; Cui C; Cabaniss LB; Waite PD; Sarver DM; Mamaeva OA; MacDougall M Cells Tissues Organs; 2016; 201(1):26-37. PubMed ID: 26613250 [TBL] [Abstract][Full Text] [Related]
13. Dynamic morphological changes in the skulls of mice mimicking human Apert syndrome resulting from gain-of-function mutation of FGFR2 (P253R). Du X; Weng T; Sun Q; Su N; Chen Z; Qi H; Jin M; Yin L; He Q; Chen L J Anat; 2010 Aug; 217(2):97-105. PubMed ID: 20557404 [TBL] [Abstract][Full Text] [Related]
14. FGFR2 mutation confers a less drastic gain of function in mesenchymal stem cells than in fibroblasts. Yeh E; Atique R; Ishiy FA; Fanganiello RD; Alonso N; Matushita H; da Rocha KM; Passos-Bueno MR Stem Cell Rev Rep; 2012 Sep; 8(3):685-95. PubMed ID: 22048896 [TBL] [Abstract][Full Text] [Related]
15. Abnormalities in cartilage and bone development in the Apert syndrome FGFR2(+/S252W) mouse. Wang Y; Xiao R; Yang F; Karim BO; Iacovelli AJ; Cai J; Lerner CP; Richtsmeier JT; Leszl JM; Hill CA; Yu K; Ornitz DM; Elisseeff J; Huso DL; Jabs EW Development; 2005 Aug; 132(15):3537-48. PubMed ID: 15975938 [TBL] [Abstract][Full Text] [Related]
16. Novel molecular pathways elicited by mutant FGFR2 may account for brain abnormalities in Apert syndrome. Yeh E; Fanganiello RD; Sunaga DY; Zhou X; Holmes G; Rocha KM; Alonso N; Matushita H; Wang Y; Jabs EW; Passos-Bueno MR PLoS One; 2013; 8(4):e60439. PubMed ID: 23593218 [TBL] [Abstract][Full Text] [Related]
17. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts. Ang BU; Spivak RM; Nah HD; Kirschner RE J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451 [TBL] [Abstract][Full Text] [Related]
18. FGFR2 mutation in a patient with Apert syndrome associated with humeroradial synostosis. Kanauchi Y; Muragaki Y; Ogino T; Takahara M; Tsuchida H; Ishigaki D Congenit Anom (Kyoto); 2003 Dec; 43(4):302-5. PubMed ID: 15041782 [TBL] [Abstract][Full Text] [Related]
19. Deformed Skull Morphology Is Caused by the Combined Effects of the Maldevelopment of Calvarias, Cranial Base and Brain in FGFR2-P253R Mice Mimicking Human Apert Syndrome. Luo F; Xie Y; Xu W; Huang J; Zhou S; Wang Z; Luo X; Liu M; Chen L; Du X Int J Biol Sci; 2017; 13(1):32-45. PubMed ID: 28123344 [TBL] [Abstract][Full Text] [Related]
20. Morphological comparison of the craniofacial phenotypes of mouse models expressing the Apert FGFR2 S252W mutation in neural crest- or mesoderm-derived tissues. Heuzé Y; Singh N; Basilico C; Jabs EW; Holmes G; Richtsmeier JT Bone; 2014 Jun; 63():101-9. PubMed ID: 24632501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]